MyFinsight
Home
Blog
About
Back
Income Statement
summitplc-logo_05fd32df-svg
Summit Therapeutics Inc. (SMMT)
summitplc-logo_05fd32df-svg
Summit Therapeutics Inc. (SMMT)
source: myfinsight.com
Comprehensive loss
-$215,733K
(61.88%↑ Y/Y)
Foreign currency
translation adjustments
$34K
(117.99%↑ Y/Y)
Net loss
-$215,700K
(61.87%↑ Y/Y)
Unrealized loss on
short-term investments
-$67K
Other income, net
$4,796K
(75.74%↑ Y/Y)
Total operating
expenses
$220,496K
(-61.21%↓ Y/Y)
Research and development
$157,733K
(-24.17%↓ Y/Y)
General and
administrative
$62,763K
(-82.59%↓ Y/Y)
Back